EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Hepatic Flare Following Effective Antiretroviral Therapy Is Associated With HBsAg Seroclearance in HBV/HIV‐1 Co‐Infection

Weiyin Lin iD, Yaozu He, Fei Gu, Fengyu Hu, Haisheng Yu iD, Hong Li, Cong Liu, Xiaoping Tang, Weiping Cai, Linghua Li iD

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.70114 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Weiyin Lin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou Medical Research Institute of Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: HIV Infections, Hepatitis B Surface Antigens, Coinfection, HIV-1. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: This study was funded by Guangdong Basic and Applied Basic Research Foundation (grant number: 2021A1515220160), Medical Key Discipline Program of Guangzhou-Vir….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Little is known about the clinical significance of hepatic flare following effective antiretroviral therapy (ART) on HBsAg seroclearance and prognosis in HBV/HIV co‐infection. This observational cohort study recruited HBV/HIV‐1 co‐infected patients from the China National Free Antiretroviral Treatment Program. We obtained longitudinal information on demographic characteristics, clinical indicators, and treatment outcomes. Hepatic flare was defined as an elevation of ALT of more than five times the upper limit of the normal range without an upsurge of HBV DNA or HBsAg at any time point between ART initiation and 12 months. Among the 1354 enrolled patients, 98.7% received two anti‐HBV drugs containing ART and 95.1% achieved good viral control. Hepatic flare was observed in 88 (6.5%) patients and was more frequent in those with lower baseline immune function but subsequently enhanced immune reconstitution. Over a median follow‐up of 4.7 years, we observed 99 HBsAg seroclearance, 9 hepatic events, 6 HIV‐associated malignancy, 3 non‐HIV‐associated malignancy, and 3 all‐cause mortality. The 3‐, 5‐, and 10‐year cumulative incidence of HBsAg seroclearance was 6.4%, 8.9%, and 12.9%, respectively. Compared to patients without hepatic flare, patients with hepatic flare had significantly higher rates of HBsAg seroclearance (13.6% vs. 6.9%, p = 0.018) but had no recorded adverse outcome. Multivariate analysis with different models indicated that hepatic flare was independently associated with HBsAg seroclearance especially in patients with low immune function, normal ALT, and high levels of HBV DNA and HBsAg at baseline. In HBV/HIV‐1 co‐infection, hepatic flare following effective ART is associated with HBsAg seroclearance. HBV‐specific T cells immune reconstitution may represent a potential mechanism which deserves further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHepatitis B Surface AntigensCoinfectionHIV-1HumansMaleFemaleAdultMiddle AgedChinaHepatitis BDNA, ViralCohort StudiesAnti-Retroviral AgentsAlanine TransaminaseTreatment OutcomeHepatitis B virusAntiretroviral Therapy, Highly ActiveHepatitis B, ChronicViral LoadLiver

Stichwörter der Autor:innen

HBV/HIV‐1 co‐infectionHBsAg seroclearancehepatic flareimmune reconstitution

Substanzen

Hepatitis B Surface AntigensDNA, ViralAnti-Retroviral AgentsAlanine Transaminase

Autor:innen und Institutionen

  • Guangzhou Medical Research Institute of Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
  • Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
  • Institute of Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.

ORCID-Profile: Weiyin Lin, Haisheng Yu, Linghua Li

Förderung

  • This study was funded by Guangdong Basic and Applied Basic Research Foundation (grant number: 2021A1515220160), Medical Key Discipline Program of Guangzhou-Vir…

Zitieren

APA

Lin, W., He, Y., Gu, F., Hu, F., Yu, H., Li, H., Liu, C., Tang, X., Cai, W., & Li, L. (2024). Hepatic Flare Following Effective Antiretroviral Therapy Is Associated With HBsAg Seroclearance in HBV/HIV‐1 Co‐Infection. Journal of Medical Virology. https://doi.org/10.1002/jmv.70114

Vancouver

Lin W, He Y, Gu F, Hu F, Yu H, Li H, et al. Hepatic Flare Following Effective Antiretroviral Therapy Is Associated With HBsAg Seroclearance in HBV/HIV‐1 Co‐Infection. Journal of Medical Virology. 2024. doi:10.1002/jmv.70114

BibTeX
@article{Lin2024,
  author = {Lin, Weiyin and He, Yaozu and Gu, Fei and Hu, Fengyu and Yu, Haisheng and Li, Hong and Liu, Cong and Tang, Xiaoping and Cai, Weiping and Li, Linghua},
  title = {Hepatic Flare Following Effective Antiretroviral Therapy Is Associated With HBsAg Seroclearance in HBV/HIV‐1 Co‐Infection},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.70114}
}
Kostenlos starten →